Fengxiang Wei
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- DNA Repair Mechanisms
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
Papers in
-
- DNA Repair Mechanisms 8
- Wnt/β-catenin signaling in development and cancer 5
- Cancer therapeutics and mechanisms 4
- RNA modifications and cancer 3
- Cancer-related gene regulation 3
- Oncology 16
- Cancer-related Molecular Pathways 9
- Cancer Cells and Metastasis 3
- Polyomavirus and related diseases 3
- Co-authors
- Damu Tang (18 shared papers)Lizhi He (7 shared papers)Yanyun Xie (6 shared papers)Lijian Tao (6 shared papers)Xiaozeng Lin (12 shared papers)Jenny Yan (1 shared paper)Diane Ojo (7 shared papers)Judy Yan (7 shared papers)
- Journals
- Oncotarget (3 papers)Cellular Signalling (3 papers)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (3 papers)Scientific Reports (2 papers)Cancers (2 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Fengxiang Wei
48 papers receiving 813 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 151
- Molecular Biology 543
- Oncology 192
- Cell Biology 102
- Toxicology 14
Countries citing papers authored by Fengxiang Wei
This map shows the geographic impact of Fengxiang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxiang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxiang Wei more than expected).
Fields of papers citing papers by Fengxiang Wei
This network shows the impact of papers produced by Fengxiang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxiang Wei. The network helps show where Fengxiang Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengxiang Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 74 | |
| 2 | 2010 | 58 | |
| 3 | 2011 | 54 | |
| 4 | 2012 | 50 | |
| 5 | 2009 | 46 | |
| 6 | 2016 | 40 | |
| 7 | 2021 | 40 | |
| 8 | 2014 | 38 | |
| 9 | 2015 | 38 | |
| 10 | 2018 | 32 | |
| 11 | 2014 | 28 | |
| 12 | 2012 | 23 | |
| 13 | 2017 | 22 | |
| 14 | 2010 | 20 | |
| 15 | 2020 | 19 | |
| 16 | 2023 | 18 | |
| 17 | 2014 | 17 | |
| 18 | 2016 | 17 | |
| 19 | 2012 | 16 | |
| 20 | 2019 | 16 |
About Fengxiang Wei
Fengxiang Wei is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Rheumatology, having authored 49 papers that have together received 823 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), DNA Repair Mechanisms (8 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Cells and Metastasis (3 papers), Polyomavirus and related diseases (3 papers), RNA modifications and cancer (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (151 citations), Molecular Biology (543 citations), Oncology (192 citations), Cell Biology (102 citations) and Toxicology (14 citations). Fengxiang Wei has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Damu Tang, Lizhi He, Yanyun Xie, Lijian Tao, Xiaozeng Lin, Jenny Yan, Diane Ojo, Judy Yan, Nicholas Wong and Pierre Major. Their work appears in journals such as Oncotarget, Cellular Signalling, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Scientific Reports and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.